Avanos Historical Income Statement

AVNS Stock

USD 16.57 0.06 0.36%

Historical analysis of Avanos Medical income statement accounts such as Interest Expense of 16.1 M, Selling General Administrative of 286.2 M or Total Revenue of 909.2 M can show how well Avanos Medical performed in making a profits. Evaluating Avanos Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Avanos Medical's future profits or losses.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Avanos Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Avanos Medical is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avanos Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Avanos Stock please use our How to Invest in Avanos Medical guide.

About Avanos Income Statement Analysis

Avanos Medical Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Avanos Medical shareholders. The income statement also shows Avanos investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Avanos Medical Income Statement Chart

At this time, Avanos Medical's Tax Provision is comparatively stable compared to the past year. Interest Income is likely to gain to about 5 M in 2025, whereas Selling General Administrative is likely to drop slightly above 286.2 M in 2025.

Selling General Administrative Total Revenue Gross Profit Other Operating Expenses Net Income From Continuing Ops

Total Revenue

Total revenue comprises all receipts Avanos Medical generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Avanos Medical minus its cost of goods sold. It is profit before Avanos Medical operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Avanos Medical. It is also known as Avanos Medical overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from Avanos Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Avanos Medical current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avanos Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Avanos Stock please use our How to Invest in Avanos Medical guide.At this time, Avanos Medical's Tax Provision is comparatively stable compared to the past year. Interest Income is likely to gain to about 5 M in 2025, whereas Selling General Administrative is likely to drop slightly above 286.2 M in 2025.

	2022	2024	2025 (projected)
Interest Expense	10M	17.3M	16.1M
Depreciation And Amortization	41.1M	41.5M	43.0M

Interest Expense Depreciation And Amortization

Avanos Medical income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Discontinued Operations	Net Income From Continuing Ops	Non Operating Income Net Other	Tax Provision	Interest Income	Non Recurring	Extraordinary Items	Net Interest Income	Reconciled Depreciation	Selling And Marketing Expenses
Depreciation And Amortization		-0.02	0.66	0.73	0.63	0.77	0.11	0.49	0.22	0.58	0.75	0.52	0.1	-0.25	0.0	0.51	-0.6	-0.12	-0.19	-0.59	0.61	0.26	-0.6	-0.77	0.8	0.26
Interest Expense	-0.02		0.16	-0.35	-0.42	-0.28	-0.72	-0.53	0.34	-0.5	-0.32	0.32	-0.76	-0.51	-0.57	-0.69	0.52	-0.54	-0.03	0.37	-0.46	-0.08	0.52	0.0	-0.12	-0.08
Selling General Administrative	0.66	0.16		0.55	0.56	0.62	-0.09	0.27	0.46	0.34	0.6	0.93	-0.1	-0.33	-0.17	0.29	-0.39	-0.2	0.17	-0.34	0.42	0.53	-0.39	-0.48	0.49	0.53
Total Revenue	0.73	-0.35	0.55		0.97	0.99	0.4	0.9	0.12	0.93	0.99	0.33	0.4	-0.21	0.18	0.87	-0.85	0.03	-0.12	-0.69	0.85	0.24	-0.86	-0.83	0.79	0.24
Gross Profit	0.63	-0.42	0.56	0.97		0.95	0.5	0.94	0.17	0.95	0.96	0.33	0.5	-0.13	0.29	0.9	-0.84	0.12	-0.01	-0.66	0.84	0.35	-0.85	-0.78	0.77	0.35
Other Operating Expenses	0.77	-0.28	0.62	0.99	0.95		0.33	0.84	0.16	0.88	0.99	0.42	0.33	-0.25	0.12	0.82	-0.83	-0.02	-0.13	-0.68	0.83	0.26	-0.83	-0.83	0.79	0.26
Operating Income	0.11	-0.72	-0.09	0.4	0.5	0.33		0.61	0.02	0.58	0.37	-0.22	1.0	0.76	0.93	0.66	-0.31	0.86	0.16	-0.19	0.3	0.09	-0.31	-0.27	0.29	0.09
Ebit	0.49	-0.53	0.27	0.9	0.94	0.84	0.61		-0.01	0.99	0.88	0.01	0.61	-0.04	0.39	0.94	-0.86	0.18	-0.02	-0.68	0.86	0.22	-0.86	-0.76	0.72	0.22
Research Development	0.22	0.34	0.46	0.12	0.17	0.16	0.02	-0.01		0.02	0.15	0.61	0.0	0.04	0.24	-0.14	0.07	-0.01	0.5	-0.11	-0.01	0.51	0.07	-0.29	0.14	0.51
Ebitda	0.58	-0.5	0.34	0.93	0.95	0.88	0.58	0.99	0.02		0.91	0.08	0.58	-0.07	0.37	0.94	-0.88	0.15	-0.04	-0.71	0.88	0.24	-0.88	-0.8	0.77	0.24
Cost Of Revenue	0.75	-0.32	0.6	0.99	0.96	0.99	0.37	0.88	0.15	0.91		0.39	0.37	-0.23	0.16	0.85	-0.86	0.0	-0.14	-0.71	0.85	0.36	-0.86	-0.84	0.83	0.36
Total Operating Expenses	0.52	0.32	0.93	0.33	0.33	0.42	-0.22	0.01	0.61	0.08	0.39		-0.24	-0.28	-0.21	-0.01	-0.13	-0.21	0.17	-0.19	0.16	0.56	-0.14	-0.32	0.32	0.56
Income Before Tax	0.1	-0.76	-0.1	0.4	0.5	0.33	1.0	0.61	0.0	0.58	0.37	-0.24		0.76	0.92	0.67	-0.33	0.86	0.17	-0.21	0.32	0.08	-0.33	-0.25	0.27	0.08
Total Other Income Expense Net	-0.25	-0.51	-0.33	-0.21	-0.13	-0.25	0.76	-0.04	0.04	-0.07	-0.23	-0.28	0.76		0.84	0.08	0.28	0.93	0.24	0.27	-0.29	-0.06	0.28	0.27	-0.24	-0.06
Net Income	0.0	-0.57	-0.17	0.18	0.29	0.12	0.93	0.39	0.24	0.37	0.16	-0.21	0.92	0.84		0.41	-0.11	0.84	0.31	-0.12	0.11	0.17	-0.11	-0.19	0.19	0.17
Income Tax Expense	0.51	-0.69	0.29	0.87	0.9	0.82	0.66	0.94	-0.14	0.94	0.85	-0.01	0.67	0.08	0.41		-0.86	0.3	-0.01	-0.62	0.85	0.16	-0.87	-0.62	0.62	0.16
Discontinued Operations	-0.6	0.52	-0.39	-0.85	-0.84	-0.83	-0.31	-0.86	0.07	-0.88	-0.86	-0.13	-0.33	0.28	-0.11	-0.86		0.14	-0.02	0.9	-0.99	-0.27	1.0	0.71	-0.68	-0.27
Net Income From Continuing Ops	-0.12	-0.54	-0.2	0.03	0.12	-0.02	0.86	0.18	-0.01	0.15	0.0	-0.21	0.86	0.93	0.84	0.3	0.14		0.09	0.26	-0.16	-0.05	0.14	0.12	-0.07	-0.05
Non Operating Income Net Other	-0.19	-0.03	0.17	-0.12	-0.01	-0.13	0.16	-0.02	0.5	-0.04	-0.14	0.17	0.17	0.24	0.31	-0.01	-0.02	0.09		-0.14	0.12	0.12	-0.02	0.0	-0.3	0.12
Tax Provision	-0.59	0.37	-0.34	-0.69	-0.66	-0.68	-0.19	-0.68	-0.11	-0.71	-0.71	-0.19	-0.21	0.27	-0.12	-0.62	0.9	0.26	-0.14		-0.91	-0.34	0.9	0.74	-0.67	-0.34
Interest Income	0.61	-0.46	0.42	0.85	0.84	0.83	0.3	0.86	-0.01	0.88	0.85	0.16	0.32	-0.29	0.11	0.85	-0.99	-0.16	0.12	-0.91		0.25	-0.99	-0.75	0.67	0.25
Non Recurring	0.26	-0.08	0.53	0.24	0.35	0.26	0.09	0.22	0.51	0.24	0.36	0.56	0.08	-0.06	0.17	0.16	-0.27	-0.05	0.12	-0.34	0.25		-0.28	-0.25	0.45	1.0
Extraordinary Items	-0.6	0.52	-0.39	-0.86	-0.85	-0.83	-0.31	-0.86	0.07	-0.88	-0.86	-0.14	-0.33	0.28	-0.11	-0.87	1.0	0.14	-0.02	0.9	-0.99	-0.28		0.71	-0.68	-0.28
Net Interest Income	-0.77	0.0	-0.48	-0.83	-0.78	-0.83	-0.27	-0.76	-0.29	-0.8	-0.84	-0.32	-0.25	0.27	-0.19	-0.62	0.71	0.12	0.0	0.74	-0.75	-0.25	0.71		-0.87	-0.25
Reconciled Depreciation	0.8	-0.12	0.49	0.79	0.77	0.79	0.29	0.72	0.14	0.77	0.83	0.32	0.27	-0.24	0.19	0.62	-0.68	-0.07	-0.3	-0.67	0.67	0.45	-0.68	-0.87		0.45
Selling And Marketing Expenses	0.26	-0.08	0.53	0.24	0.35	0.26	0.09	0.22	0.51	0.24	0.36	0.56	0.08	-0.06	0.17	0.16	-0.27	-0.05	0.12	-0.34	0.25	1.0	-0.28	-0.25	0.45

Click cells to compare fundamentals

Avanos Medical Account Relationship Matchups

Avanos Medical income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Depreciation And Amortization	42.9M	38.3M	41.1M	46.1M	41.5M	43.0M
Interest Expense	15M	15.6M	3.3M	10M	17.3M	16.1M
Selling General Administrative	332.6M	300.3M	341.9M	335M	301.5M	286.2M
Total Revenue	714.8M	744.6M	820M	673.3M	606.0M	909.2M
Gross Profit	373.3M	364.3M	450M	379.7M	341.7M	377.9M
Other Operating Expenses	760.9M	735.7M	746M	669.1M	602.2M	854.8M
Operating Income	(46.1M)	8.9M	74M	4.2M	3.8M	3.6M
Ebit	(44.9M)	(29.4M)	36.7M	4.5M	4.1M	3.8M
Ebitda	(2M)	8.9M	77.8M	50.6M	45.5M	43.3M
Cost Of Revenue	341.5M	380.3M	370M	293.6M	264.2M	251.0M
Total Operating Expenses	419.4M	355.4M	376M	375.5M	338.0M	323.5M
Income Before Tax	(60.5M)	5.8M	65.2M	(7.9M)	(7.1M)	(6.8M)
Total Other Income Expense Net	(14.4M)	44.8M	(8.8M)	(12.1M)	(13.9M)	(14.6M)
Net Income	(27.2M)	6.3M	50.5M	(61.8M)	(55.6M)	(52.8M)
Income Tax Expense	(33.3M)	600K	14.7M	2M	1.8M	1.7M
Net Income Applicable To Common Shares	(45.9M)	(27.2M)	5.2M	50.5M	45.5M	47.7M
Net Income From Continuing Ops	(27.2M)	5.2M	50.5M	(9.9M)	(11.4M)	(12.0M)
Non Operating Income Net Other	7.8M	6.7M	1.2M	200K	1.1M	2.1M
Tax Provision	(33.3M)	600K	14.7M	2M	2.3M	2.4M
Interest Income	6.7M	1.2M	200K	2.9M	2.6M	5.0M
Net Interest Income	(14.4M)	(3.1M)	(8.8M)	(12.1M)	(13.9M)	(14.6M)
Reconciled Depreciation	42.9M	38.3M	47.7M	46.1M	41.5M	34.8M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Avanos Stock Analysis

When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Avanos Historical Income Statement

About Avanos Income Statement Analysis

Avanos Medical Income Statement Chart

Total Revenue

Gross Profit

Other Operating Expenses

Avanos Medical income statement Correlations

Avanos Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Avanos Medical income statement Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Avanos Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Income Before Tax	+ 1.0	Operating Income
Extraordinary Items	+ 1.0	Discontinued Operations
Selling And Marketing Expenses	+ 1.0	Non Recurring
Other Operating Expenses	+ 0.99	Total Revenue
Cost Of Revenue	+ 0.99	Total Revenue
Cost Of Revenue	+ 0.99	Other Operating Expenses

Extraordinary Items	- 0.99	Interest Income
Interest Income	- 0.99	Discontinued Operations
Interest Income	- 0.91	Tax Provision
Extraordinary Items	- 0.88	Ebitda
Discontinued Operations	- 0.88	Ebitda
Reconciled Depreciation	- 0.87	Net Interest Income